The program objective is to train promising new scientists in mechanisms of cardiovascular diseases, experimental strategies and technologies necessary for development of novel molecular therapeutics. The theme of the program is signal transduction within a multidisciplinary, integrated program that focuses on events involved in cardiac and vascular development, hypertension, genes/proteins involved in myocardial hypertrophy and failure, conduction abnormalities, structure and function of signaling molecules and signaling events in vascular smooth muscle, cardiac myocytes and conducting tissue. Training resources include molecular genetics with transgenic and knockout facilities, microscopy, image analysis, mass spectrometry and applied chemistry. Guidelines for entering predoctoral trainees include baccalaureate degree, GRE scores, letters of recommendation with prior research experience preferred. Guidelines for entering postdoctoral trainees include the Ph.D. and/or M.D. degrees; prior research experience and letters of recommendation. We value trainees with diverse backgrounds. Financial support is requested for 2, 4, 6, 6, 6, predoctoral trainees and 8 postdoctoral trainees/year for years 26-30. Training participants are faculty in Pharmacology, Medicine (Cardiology, Endocrinology, Rheumatology), Cell Biology and Anatomy, Biochemistry, Physiology and Surgery. Predoctoral trainees enter the Biomedical Sciences First Year Curriculum and then join the Cardiovascular Biology track in their second year as part of the Cell and Molecular Pharmacology and Experimental Therapeutics Ph.D program or the Cell and Molecular Biology and Pathobiology Ph.D. program. Thereafter, they take advanced courses in cardiovascular biology and those required by their individual Ph.D. program and carry out their dissertation research. Postdoctoral training emphasizes laboratory investigation with access to basic and advanced courses. All predoctoral and postdoctoral trainees meet with visiting scientists, present at local seminars and national meetings, and participate in joint journal clubs and seminars.
Our aim i s to produce outstanding investigators with a broad insight into cardiovascular dysfunction who will make significant contributions to the understanding of these disorders and development of therapies for cardiovascular diseases.
| Herr, Daniel J; Baarine, Mauhamad; Aune, Sverre E et al. (2018) HDAC1 localizes to the mitochondria of cardiac myocytes and contributes to early cardiac reperfusion injury. J Mol Cell Cardiol 114:309-319 |
| Stephenson, Sarah E; Wilson, Carole L; Crothers, Kristina et al. (2018) Impact of HIV infection on ?1-antitrypsin in the lung. Am J Physiol Lung Cell Mol Physiol 314:L583-L592 |
| Kimbrough, Denise; Wang, Sabina H; Wright, Lillianne H et al. (2018) HDAC inhibition helps post-MI healing by modulating macrophage polarization. J Mol Cell Cardiol 119:51-63 |
| Cheng, Qi; Patel, Kunal; Lei, Biao et al. (2018) Donor pretreatment with nebulized complement C3a receptor antagonist mitigates brain-death induced immunological injury post-lung transplant. Am J Transplant 18:2417-2428 |
| Tran, Danh T; Esckilsen, Scott; Mulligan, Jennifer et al. (2018) Impact of Mitochondrial Permeability on Endothelial Cell Immunogenicity in Transplantation. Transplantation 102:935-944 |
| Wright, Lillianne H; Herr, Daniel J; Brown, Symone S et al. (2018) Angiokine Wisp-1 is increased in myocardial infarction and regulates cardiac endothelial signaling. JCI Insight 3: |
| Arbra, Chase A; Fann, Stephen A (2017) Parastomal Evisceration: Rare Complication after Total Abdominal Colectomy. Am Surg 83:379-380 |
| Richards, Dylan; Jia, Jia; Yost, Michael et al. (2017) 3D Bioprinting for Vascularized Tissue Fabrication. Ann Biomed Eng 45:132-147 |
| Richards, Dylan J; Coyle, Robert C; Tan, Yu et al. (2017) Inspiration from heart development: Biomimetic development of functional human cardiac organoids. Biomaterials 142:112-123 |
| Toomer, Katelynn A; Fulmer, Diana; Guo, Lilong et al. (2017) A role for primary cilia in aortic valve development and disease. Dev Dyn 246:625-634 |
Showing the most recent 10 out of 123 publications
